Skip to content

MUNDIPHARMA

Active Private limited companyfounded 2003active for 23 yearsDe Kleetlaan 4, 1831 Machelen (Brab.)KBO/BCE: BE 0479.294.321 subsidiary of

Lifetime

23 annual accounts with figures on one time axis
peak of €25.4m in 2019
€5.0m▼ 6.2%
lowest -€5.6m in 2013
€296,147▲ 94.6%
peak of €8.1m in 2025
€8.1m▲ 3.8%
€2.1m▲ 45.8%
peak of 46.6 FTE in 2012
-not published
Board2 names since 2003
1 director
Owners10 names in the annual accountsall names
  
Documentsfilings and deeds
27-07-20264 days before the deadline
2025financial year
Result from €152,181 to €296,147 acts as permanent representative 11-09Debts from €1.5m to €2.1mCash from €7.3m to €1.7m

Key points

from the 2025 annual accounts

Equity

€8.1m ▲ 3.8%

MUNDIPHARMA has made a profit without a break since 2016.

Result

€296,147 ▲ 94.6%
€152,0002024€296,0002025

The result rose in 2025 from €152,181 to €296,147.

Payment terms

118 days to suppliers
Suppliers
82 to 118
Customers
56 to 122

MUNDIPHARMA pays its suppliers 36 days later than in 2024. Customers pay 66 days later.

Filings

23 annual accounts since 2003
AprilJune31 JulyOctober20102020

Five of the last ten came late. The 2019 accounts came in latest, 487 days after the end of the period.

Position in the sector

79.1%

Higher solvency than 86% of companies in wholesale trade. The sector median is 43.8%, over 3,805 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,902 companies had the same profile as MUNDIPHARMA has now. Each dot stands for 5 companies, two years later.

97.7%
were still trading
2.1%
stopped another way
0.1%
went bankrupt
  • Medium-sized
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,902 companies, not a prediction for MUNDIPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 10-01-2003
Auditor,
  • 60.45%annual accounts 2023
  • 14%annual accounts 2023
  • 14%annual accounts 2023
and 2 other shareholdersBoard & ownership

Recent changes

reappointed as statutory auditor acts as permanent representative · General meeting of 02-12-2025 · Gazette deed
acts as permanent representative Board meeting of 19-08-2025 · Gazette deed
and act as permanent representatives Gazette deed
Registered office moved from Mechelen to Diegem The registered office moved from Kardinaal Mercierplein 2, B-2800 Mechelen to De Kleetlaan 4, 1831 Diegem · Board meeting of 30-01-2023 · Gazette deed
All 80 events

Comparable companies

same main activity, similar in size and age
Company
MUNDIPHARMA Machelen (Brab.) €5.0m 3.0% 79.1% -
INTEGRA LS (BENELUX) Ghent €7.1m 5.4% 87.0% 18.1
EISAI Leuven €7.6m 4.0% 65.1% 12.6
Abbott Rapid Diagnostics Zaventem €7.9m 3.7% 89.1% 7.9
CORIS BIOCONCEPT Gembloux €5.5m -7.2% 82.1% 31.2
MEDECO Kontich €5.7m -3.6% -12.5% 2.6
ICB Brussels €4.7m 11.4% 46.5% 2
-10%0%10%20%€5m€50m€500m€5bnMUNDIPHARMAEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as MUNDIPHARMA: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €4.2m and €21m, founded between 1995 and 2007.

Official details

Source: KBO
Status
Active since 13-01-2003Normal situation
Registered office
38 active companies are registered at this addressSource: KBO register, as of 22 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2022
Establishment unit
2.144.899.9291831 Machelen (Brab.), registered on 07-02-2003
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

€10.2m▲ 10.4%
Filing
Filed on 27-07-2026, 4 days before the end of the filing period
Financials

Companies linked to MUNDIPHARMA

Shareholders

  • 0.05%

Insights on MUNDIPHARMA

MUNDIPHARMA has existed since 2003. Turnover fell from €8.9m in 2012 to €5.0m in 2025.

Turnover has fallen every year since 2019. Solvency fell in 2025 from 84.2% to 79.1% because of higher debts to suppliers.

holds 60.45% of the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MUNDIPHARMA

What is the company number of MUNDIPHARMA?
The company number of MUNDIPHARMA is 0479.294.321. The VAT number is the same number with BE in front: BE 0479.294.321.
Where is MUNDIPHARMA based?
The registered office is at De Kleetlaan 4, 1831 Machelen (Brab.).Company details
What does MUNDIPHARMA do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of MUNDIPHARMA?
MUNDIPHARMA is a private limited company (BV).
When was MUNDIPHARMA founded?
MUNDIPHARMA was founded on 13-01-2003.
Is MUNDIPHARMA still active?
Yes, MUNDIPHARMA is an active enterprise in the KBO register.
How many employees does MUNDIPHARMA have?
MUNDIPHARMA had an average of 2.2 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
Which joint committee does MUNDIPHARMA fall under?
In its 2022 annual accounts, MUNDIPHARMA states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of MUNDIPHARMA?
The turnover of MUNDIPHARMA was €5.0m in financial year 2025, according to the filed annual accounts.
Is MUNDIPHARMA profitable?
In financial year 2025, MUNDIPHARMA made a profit of €296,147.
Where can I find the annual accounts of MUNDIPHARMA?
MUNDIPHARMA filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MUNDIPHARMA due?
MUNDIPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.